Cureus . A Review of Acute Myocardial Injury in Coronavirus Disease 2019

[tetano]

Cureus


. 2020 Jun 3;12(6):e8426.
doi: 10.7759/cureus.8426.
A Review of Acute Myocardial Injury in Coronavirus Disease 2019


Anupama B K ¹ , Debanik Chaudhuri ²



Affiliations

• PMID: 32642342
• PMCID: PMC7336683
• DOI: 10.7759/cureus.8426

Abstract

In December 2019, an outbreak of pneumonia caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), occurred in Wuhan, Hubei province, China, and it has spread rapidly across the world, causing the coronavirus disease 2019 (COVID-19) pandemic. Although SARS-CoV-2 infection predominantly results in pulmonary issues, accumulating evidence suggests the increased frequency of a variety of cardiovascular complications in patients with COVID-19. Acute cardiac injury, defined as elevated cardiac troponin levels, is the most reported cardiac abnormality in COVID-19 and strongly associated with mortality. In this article, we summarize the currently available data on the association of SARS-CoV-2 and COVID-19 with acute myocardial injury.

Keywords: acute myocardial injury; cardiac troponin; covid-19; myocarditis; sars-cov-2.